Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > GUD and INFLATION
View:
Post by Stockoman1 on Apr 22, 2022 8:12pm

GUD and INFLATION

With a stagnant stock price, and paying no dividend, inflation has eroded the value of Gud stock held in your investment account.........just sayin...
Comment by MrMugsy on Apr 22, 2022 11:16pm
It is true. And the same could have been said about Paladin Labs throughout their early years. What your initial investment in Paladin gave you was a CAGR of 27% over 19 years of patient business development.  Addiitional money invested in later years would have returned much higher CAGR. It's also important to understand that Knight may not be acquired in the same manner that Paladin ...more  
Comment by Snowballgrowth on Apr 23, 2022 9:41am
You can't compare Palladin Capital base vs GUD. You can't do this. GUD made the mistake to raise too much cash + invest in funds. 
Comment by MrMugsy on Apr 23, 2022 11:23am
"You can't compare Palladin Capital base vs GUD. You can't do this. GUD made the mistake to raise too much cash + invest in funds." ---------------------------------------- That was no mistake ... There are roughly 8x more shares. That is understood and must be considered in any analysis Our revenue is 10x that of Paladin's - after year 7 What I'm saying is - after 7 ...more  
Comment by EbbFlow88 on Apr 23, 2022 9:53am
Yes, that has been the truth but look forward. Currently, if you subtract cash and investmenets (which have been earning a double digit return) you are left with a market cap of around $270M. Divide cash flow of 40M by market cap and you get about 15% cash yield.  Even with cash and investments earning nothing then you get your return of 7.5% a year over time which will sooner or later be ...more  
Comment by Snowballgrowth on Apr 23, 2022 10:32am
1) Do you have some exemples ? aren't they mostly regulated pricing for most of them ? 2) I heard that for the 7 years. This undeployed cash is a big negative.  I still own my position but I'm not happy with capital allocation there. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities